If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares ...
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.
Definium Therapeutics Inc, Compass Pathways Plc, ATAI Beckley Inc, AdvisorShares Psychedelics ETF. Read 's Market Analysis on Investing.com ...
The recent market rotation continued before and during the war, as value stocks posted gains across the market-capitalization ...
Ethereum whale bets on SHIB and PEPE, XRP sees $25 million comeback, and Binance adds 7 AI, gold, and DeFi pairs. Plus, key ...
Medpace is a global late-stage contract research organization, or CRO, that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and ...
Read about 6 key trends as U.S. stocks hit record highs: tech-led gains, CRE/CMBS stress, regional bank exposure, and ...
Kailera Therapeutics, a clinical-stage biotech focused on obesity treatments, just reported a notable insider buy in recent ...
April 27 (Reuters) - Eli Lilly said on Monday it would buy privately-held blood cancer treatment developer Ajax ...
Investor's Business Daily on MSN
Biotech skyrockets nearly 50% on a potential game-changer in hair loss
Veradermics' oral version of Rogaine led to "rapid and robust hair growth" for men with pattern hair loss. The recent IPO ...
Leveraged ETFs saw sharp gains last week, fueled by sector-specific news and a historic surge of over $100 billion into U.S.
ImmunityBio IBRX has delivered a stunning rerating in 2026. After a move like this, investors often stop debating the story ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results